ILLUMENATE EU Randomized Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 294 participants.
Also called NCT01858363
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 294 participants
- Sponsor
- Registry
-
NCT01858363
-
- Other papers using this trial's data
- Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon)
- Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT01858363. Randomized; single masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2016-03 (actual). Results posted on 2021-10-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ILLUMENATE EU Randomized Clinical Trial
- Acronym
- EU RCT
- Condition
- Peripheral Arterial Disease
- Condition
- Claudication
- Intervention (Device)
- CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
- Intervention (Device)
- Bare Percutaneous Transluminal Angioplasty Balloon Catheter
- Lead sponsor
- Spectranetics Corporation
Record details
- Record id
cardio:ct-nct01858363- Content hash
f6aa3b760c34c824eb9e0e19e6d805dd7f24871897c2911d8942236a356c7590